Cargando…

Oxyntomodulin increases intrinsic heart rate through the glucagon receptor

Two hormones from the gastrointestinal tract, glucagon and oxyntomodulin (OXM), vigorously elevate the intrinsic heart rate (I(HR)) of mice. We have previously shown that OXM influences murine heart rate (HR) independent of the glucagon-like peptide 1 (GLP-1) receptor. Here, we demonstrate using rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukharji, Auyon, Drucker, Daniel J, Charron, Maureen J, Swoap, Steven J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841047/ https://www.ncbi.nlm.nih.gov/pubmed/24303183 http://dx.doi.org/10.1002/phy2.112

Ejemplares similares

Oxyntomodulin analogue increases energy expenditure via the glucagon receptor
por: Scott, R., et al.
Publicado: (2018)

The Glucagon Receptor Is Involved in Mediating the Body Weight-Lowering Effects of Oxyntomodulin
por: Kosinski, Jennifer R., et al.
Publicado: (2012)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
por: Price, Samantha L., et al.
Publicado: (2015)

Oxyntomodulin regulates resetting of the liver circadian clock by food
por: Landgraf, Dominic, et al.
Publicado: (2015)

Increased food intake with oxyntomodulin analogues
por: Price, Samantha L., et al.
Publicado: (2015)

Action and therapeutic potential of oxyntomodulin()
por: Pocai, Alessandro
Publicado: (2013)

Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
por: Ali, Safina, et al.
Publicado: (2014)

Unraveling oxyntomodulin, GLP1's enigmatic brother
por: Pocai, Alessandro
Publicado: (2012)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
por: Baggio, Laurie L., et al.
Publicado: (2020)

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011)

Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia: Evidence for a Circulating α-Cell Growth Factor
por: Longuet, Christine, et al.
Publicado: (2013)

Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
por: Cabou, Cendrine, et al.
Publicado: (2008)

PYY(3–36) and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
por: Field, Benjamin C.T., et al.
Publicado: (2010)

Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival
por: Neumann, Ursula H., et al.
Publicado: (2016)

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
por: Pickford, Phil, et al.
Publicado: (2021)

Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 Diabetes
por: Bharmal, Sakina H., et al.
Publicado: (2020)

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2016)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
por: Lorenz, Martin, et al.
Publicado: (2017)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

D‐Ser2‐oxyntomodulin ameliorated Aβ31‐35‐induced circadian rhythm disorder in mice
por: Wang, Li, et al.
Publicado: (2019)

(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer's disease transgenic mice
por: Yang, Guang-Zhao, et al.
Publicado: (2022)

GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr(−/−) mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
por: Patel, Anita, et al.
Publicado: (2018)

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
por: McLean, Brent A., et al.
Publicado: (2022)

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish
por: Kang, Qi, et al.
Publicado: (2022)

Norepinephrine Controls Both Torpor Initiation and Emergence via Distinct Mechanisms in the Mouse
por: Swoap, Steven J., et al.
Publicado: (2008)

Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
por: Koehler, Jacqueline A., et al.
Publicado: (2009)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
por: Damond, Nicolas, et al.
Publicado: (2016)

The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice
por: Beaudry, Jacqueline L., et al.
Publicado: (2019)

An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain
por: Yin, Yanting, et al.
Publicado: (2016)

Role of Central Nervous System Glucagon-Like Peptide-1 Receptors in Enteric Glucose Sensing
por: Knauf, Claude, et al.
Publicado: (2008)

Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency
por: Wilson-Pérez, Hilary E., et al.
Publicado: (2013)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
por: Barrera, Jason G., et al.
Publicado: (2009)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice
por: Burmeister, Melissa A., et al.
Publicado: (2017)

Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
por: Picha, Kristen M., et al.
Publicado: (2008)

Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver
por: Berglund, Eric D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uhp4ltbbbv1i8alg5cspmkmu7t